ASND
Price
$263.51
Change
+$2.29 (+0.88%)
Updated
Sep 11 closing price
Capitalization
17.33B
60 days until earnings call
Intraday BUY SELL Signals
TARS
Price
$79.31
Change
-$1.81 (-2.23%)
Updated
Sep 11 closing price
Capitalization
3.71B
59 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ASND vs TARS

ASND vs TARS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ASND vs. TARS commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASND is a StrongBuy and TARS is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASND($17.3B) has a higher market cap than TARS($3.71B). ASND YTD gains are higher at: 23.577 vs. TARS (-3.139). ASND has higher annual earnings (EBITDA): 191M vs. TARS (-28.88M). ASND has more cash in the bank: 812M vs. TARS (450M). TARS has less debt than ASND: TARS (72.8M) vs ASND (450M). ASND has higher revenues than TARS: ASND (1.05B) vs TARS (606M).
ASNDTARSASND / TARS
Capitalization17.3B3.71B466%
EBITDA191M-28.88M-661%
Gain YTD23.577-3.139-751%
P/E Ratio20.24N/A-
Revenue1.05B606M173%
Total Cash812M450M180%
Total Debt450M72.8M618%
FUNDAMENTALS RATINGS
ASND vs TARS: Fundamental Ratings
ASND
TARS
OUTLOOK RATING
1..100
6991
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
53
Fair valued
PROFIT vs RISK RATING
1..100
3721
SMR RATING
1..100
1294
PRICE GROWTH RATING
1..100
4138
P/E GROWTH RATING
1..100
75100
SEASONALITY SCORE
1..100
4190

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TARS's Valuation (53) in the null industry is in the same range as ASND (78) in the Biotechnology industry. This means that TARS’s stock grew similarly to ASND’s over the last 12 months.

TARS's Profit vs Risk Rating (21) in the null industry is in the same range as ASND (37) in the Biotechnology industry. This means that TARS’s stock grew similarly to ASND’s over the last 12 months.

ASND's SMR Rating (12) in the Biotechnology industry is significantly better than the same rating for TARS (94) in the null industry. This means that ASND’s stock grew significantly faster than TARS’s over the last 12 months.

TARS's Price Growth Rating (38) in the null industry is in the same range as ASND (41) in the Biotechnology industry. This means that TARS’s stock grew similarly to ASND’s over the last 12 months.

ASND's P/E Growth Rating (75) in the Biotechnology industry is in the same range as TARS (100) in the null industry. This means that ASND’s stock grew similarly to TARS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASNDTARS
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
67%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (ASND: $263.52 vs. TARS: $79.31)
Brand notoriety: ASND and TARS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASND: 70% vs. TARS: 35%
Market capitalization -- ASND: $17.33B vs. TARS: $3.71B
ASND [@Biotechnology] is valued at $17.33B. TARS’s [@Biotechnology] market capitalization is $3.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASND’s FA Score shows that 1 FA rating(s) are green while TARS’s FA Score has 1 green FA rating(s).

  • ASND’s FA Score: 1 green, 4 red.
  • TARS’s FA Score: 1 green, 4 red.
According to our system of comparison, ASND is a better buy in the long-term than TARS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASND’s TA Score shows that 6 TA indicator(s) are bullish while TARS’s TA Score has 3 bullish TA indicator(s).

  • ASND’s TA Score: 6 bullish, 3 bearish.
  • TARS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ASND is a better buy in the short-term than TARS.

Price Growth

ASND (@Biotechnology) experienced а -2.60% price change this week, while TARS (@Biotechnology) price change was -12.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

ASND is expected to report earnings on Nov 11, 2026.

TARS is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ASND
Daily Signal:
Gain/Loss:
TARS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HCMT41.140.75
+1.86%
Direxion HCM Tactical EnhU.S.EqStratETF
RILA11.990.12
+0.97%
Indexperts Gorilla Aggressive Growth ETF
BKLC48.860.42
+0.87%
BNY Mellon US Large Cap Core Equity ETF
XTR28.850.24
+0.85%
Global X S&P 500® Tail Risk ETF
HTUS45.430.31
+0.68%
Hull Tactical US ETF

TARS and

Correlation & Price change

A.I.dvisor indicates that over the last year, TARS has been loosely correlated with IONS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TARS jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARS
1D Price
Change %
TARS100%
-2.23%
IONS - TARS
39%
Loosely correlated
-2.59%
GMAB - TARS
35%
Loosely correlated
+0.74%
ARVN - TARS
35%
Loosely correlated
-2.99%
XERS - TARS
35%
Loosely correlated
-2.87%
ARWR - TARS
35%
Loosely correlated
+0.11%
More